200709-95-1

Applied Filters:

Keyword:'200709-95-1'

Showing 11-20 of 2007 results for "200709-95-1" within Site Content

TRC Design and pLKO.1 Vector FAQs

MISSION® shRNA clones in pLKO.1-Puro vector allow bacterial culture propagation and mammalian cell selection for gene silencing studies.

GMP Annex 1: Changes in Microbial Monitoring

Listen to our podcast, GMP Annex 1: Changes in Microbial Monitoring.

Novel Perfusion Filter for N-1 Application

Novel perfusion filter and controller, along with expansion medium, intensify upstream processing, demonstrated in a case study webinar.

LSMLS Online Plate Map

LSMLS compounds are conveniently provided at 1mg per well, enough for multiple injections. These are high purity (>95%) compounds supplied in an economical, ready to use format.

Principal Component Analysis (PCA) Evaluation of Seven Commercial Ionic Liquid Capillary GC Columns

In order to cover a broad range of possible solute-stationary phase interactions, 95 solutes with varied functional groups were selected to perform stationary phase characterization.

Bioburden in EU GMP Annex 1: Risk Assessment

Panel discussion on overcoming challenges in bioburden reduction, in compliance with new EU GMP Annex 1.

CellPrime® rLR3 IGF-1 for Cell Culture

CellPrime® rLR3 enhances cell culture media formulations, promoting growth and protein production.

A Sensitive Method to Quantify HIV-1 Antibody in Mucosal Samples

Revealing the truth of pd-1/pd-l1 resistance mechanism

pLKO-1 Vector and shRNA Design Frequently Asked Questions

Frequently asked questions about pLKO-1 vector & shRNA design

Page 2 of 201